NCT06523504View on ClinicalTrials.gov

Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Myopia
Interventions
DEVICE

DIMS

wear DIMS ,and use placebo,once nightly, both eye

DRUG

The 0.02% ATP Group

wear SP, and use 0.02%ATP eye drops, once nightly, both eye

DRUG

The 0.04% ATP Group

wear SP, and use 0.04%ATP eye drops, once nightly, both eye

COMBINATION_PRODUCT

0.02%ATP+DIMS

wear DIMS, and use 0.02%ATP eye drops, once nightly, both eye

COMBINATION_PRODUCT

0.04%ATP+DIMS

wear DIMS, and use 0.04%ATP eye drops, once nightly, both eye

Trial Locations (1)

120120

RECRUITING

Tianjin Medical University Eye Hospital, Tianjin

All Listed Sponsors
collaborator

Beijing Tongren Hospital

OTHER

lead

Ruihua Wei

OTHER